相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Surface-modified magnetite nanoparticles act as aneugen-like spindle poison
Barbora Buliakova et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype
Yujin Kwon et al.
ONCOTARGET (2017)
Tailored Treatment Strategy for Locally Advanced Rectal Carcinoma Based on the Tumor Response to Induction Chemotherapy: Preliminary Results of the French Phase II Multicenter GRECCAR4 Trial
Philippe Rouanet et al.
DISEASES OF THE COLON & RECTUM (2017)
Aldehyde dehydrogenase 1A1 in stem cells and cancer
Hiroyuki Tomita et al.
ONCOTARGET (2016)
Colorectal cancer in the young, many questions, few answers
Kemal I. Deen et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Understanding the colon cancer stem cells and perspectives on treatment
Elsa N. Garza-Trevino et al.
CANCER CELL INTERNATIONAL (2015)
Krt19+/Lgr5- Cells Are Radioresistant Cancer-Initiating Stem Cells in the Colon and Intestine
Samuel Asfaha et al.
CELL STEM CELL (2015)
N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes
Cynthia A. Morgan et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Incidence and patterns of late recurrences in colon cancer patients
Anne-Marie Bouvier et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma
Kengo Nakahata et al.
PLOS ONE (2015)
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
Yongmin Yan et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Colon cancer: Cancer stem cells markers, drug resistance and treatment
Zuzana Kozovska et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
LGR5 positivity defines stem-like cells in colorectal cancer
Daniela Hirsch et al.
CARCINOGENESIS (2014)
CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
Matilde Todaro et al.
CELL STEM CELL (2014)
Aldehyde Dehydrogenase 1A1: Friend or Foe to Female Metabolism?
Jennifer M. Petrosino et al.
NUTRIENTS (2014)
Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells
Lucia Kucerova et al.
BMC CANCER (2013)
Autocrine Function of Aldehyde Dehydrogenase 1 as a Determinant of Diet- and Sex-Specific Differences in Visceral Adiposity
Rumana Yasmeen et al.
DIABETES (2013)
ALDH, CA I, and CD2AP Novel, Diagnostically Useful Immunohistochemical Markers to Identify Erythroid Precursors in Bone Marrow Biopsy Specimens
Marian A. Rollins-Raval et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance
Jan S. Moreb et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2012)
Evolvement of the treatment paradigm for metastatic colon cancer. From chemotherapy to targeted therapy
Santiago Aparo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Retinaldehyde Dehydrogenase 1 Coordinates Hepatic Gluconeogenesis and Lipid Metabolism
Florian W. Kiefer et al.
ENDOCRINOLOGY (2012)
Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells
Miroslava Matuskova et al.
JOURNAL OF GENE MEDICINE (2012)
ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets
Yuchun Luo et al.
STEM CELLS (2012)
Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells
Kristel Kemper et al.
STEM CELLS (2012)
Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application
Vindhya Koppaka et al.
PHARMACOLOGICAL REVIEWS (2012)
Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer
Ying Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Aldehyde dehydrogenase Its role as a cancer stem cell marker comes down to the specific isoform
Paola Marcato et al.
CELL CYCLE (2011)
Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer
Diego Serrano et al.
MOLECULAR CANCER (2011)
Concerted Action of Aldehyde Dehydrogenases Influences Depot-Specific Fat Formation
Barbara Reichert et al.
MOLECULAR ENDOCRINOLOGY (2011)
Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells is Primarily Due to Isoform ALDH1A3 and Its Expression is Predictive of Metastasis
Paola Marcato et al.
STEM CELLS (2011)
Colorectal Cancer Stem Cells: Biology and Therapeutic Implications
Brian J. Wilson et al.
CURRENT COLORECTAL CANCER REPORTS (2011)
Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma
Zeshaan A. Rasheed et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Charles N. Landen et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors
Krishna Penumatsa et al.
JOURNAL OF OVARIAN RESEARCH (2010)
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tomonori Tanei et al.
CLINICAL CANCER RESEARCH (2009)
Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer:: a retrospective study -: Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens
NE Sládek et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
分享论文
